SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice ; volume:17 ; number:1 ; day:27 ; month:4 ; year:2018 ; pages:1-14 ; date:12.2018
Cardiovascular diabetology ; 17, Heft 1 (27.4.2018), 1-14, 12.2018
- Creator
-
Lee, Dustin M.
- Contributor
-
Battson, Micah L.
Jarrell, Dillon K.
Hou, Shuofei
Ecton, Kayl E.
Weir, Tiffany L.
Gentile, Christopher L.
SpringerLink (Online service)
- DOI
-
10.1186/s12933-018-0708-x
- URN
-
urn:nbn:de:101:1-2018070114401588144821
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Dustin M.
- Battson, Micah L.
- Jarrell, Dillon K.
- Hou, Shuofei
- Ecton, Kayl E.
- Weir, Tiffany L.
- Gentile, Christopher L.
- SpringerLink (Online service)
Other Objects (12)
Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes
Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy
Dapagliflozin targets SGLT2/SIRT1 signaling to attenuate the osteogenic transdifferentiation of vascular smooth muscle cells
Dapagliflozin
Die Auswirkung der SGLT2-Transporter Inhibition durch Dapagliflozin auf den Natriumgehalt des Gewebes im menschlichen Körper
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats
Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis
SGLT2 inhibition improves coronary flow velocity reserve and contractility: role of glucagon signaling
Untersuchung der therapeutischen Effekte eines Interleukin-1β-Antikörpers und des SGLT2-Inhibitors Dapagliflozin auf den druckbelasteten rechten Ventrikel im Mausmodell
Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes
Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy
Dapagliflozin targets SGLT2/SIRT1 signaling to attenuate the osteogenic transdifferentiation of vascular smooth muscle cells
Dapagliflozin
Die Auswirkung der SGLT2-Transporter Inhibition durch Dapagliflozin auf den Natriumgehalt des Gewebes im menschlichen Körper
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats
Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis
SGLT2 inhibition improves coronary flow velocity reserve and contractility: role of glucagon signaling
Untersuchung der therapeutischen Effekte eines Interleukin-1β-Antikörpers und des SGLT2-Inhibitors Dapagliflozin auf den druckbelasteten rechten Ventrikel im Mausmodell
Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes
Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy
Dapagliflozin targets SGLT2/SIRT1 signaling to attenuate the osteogenic transdifferentiation of vascular smooth muscle cells
Dapagliflozin
Die Auswirkung der SGLT2-Transporter Inhibition durch Dapagliflozin auf den Natriumgehalt des Gewebes im menschlichen Körper
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats
Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis
SGLT2 inhibition improves coronary flow velocity reserve and contractility: role of glucagon signaling